Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02729831 · ClinicalTrials.gov registry record · NA

Comparative Effectiveness of Decision Support Strategies for Joint Replacement Surgery

A NA study, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
1,220
Enrollment target

NCT02729831: Completed NA study, sponsored by Massachusetts General Hospital.

NCT02729831 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 1,220 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (13% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02729831, a NA study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
1,220 participants
Enrollment target

Study Summary

This study is a 2X2 factorial randomized trial that will the examine the comparative effectiveness of two patient decision aids for hip and knee osteoarthritis (OA) as well as the impact of a surgeon-focused intervention.

Primary Outcome

Knowledge sub-score generated from responses to the Hip or Knee Decision Quality Instrument (DQI). Scores range from 0-100%, with higher score meaning higher knowledge.

Interventions

  • BEHAVIORAL Interactive decision aid
  • BEHAVIORAL Video decision aid
  • BEHAVIORAL Provider Report

Trial Details

FieldValue
Enrollment Target 1,220 participants
Start Date 2016-04
Est. Completion 2019-01
Phase NA
Massachusetts General Hospital

2,032 total trials

What the finished NCT02729831 record still lists

NCT02729831 is an interventional study that assigns participants to a tested intervention. Its 1,220 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (13% lower).

The record links to 0 conditions, and to 3 interventions - of which Interactive decision aid is the first listed.

NCT02729831 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02729831 about?

NCT02729831 is a clinical study titled "Comparative Effectiveness of Decision Support Strategies for Joint Replacement Surgery". This study is a 2X2 factorial randomized trial that will the examine the comparative effectiveness of two patient decision aids for hip and knee osteoarthritis (OA) as well as the impact of a surgeon-focused intervention.

What is the current status of trial NCT02729831?

This trial is currently completed. It is a NA study. The enrollment target is 1,220 participants. The study started on 2016-04. Estimated completion is 2019-01.

What interventions are being tested in trial NCT02729831?

The interventions under investigation include: Interactive decision aid (BEHAVIORAL), Video decision aid (BEHAVIORAL), Provider Report (BEHAVIORAL).

Who is sponsoring clinical trial NCT02729831?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02729831's enrollment target sits among peer trials

1,220 83rd of 2000 higher than 1,918 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06921785 · 1,220 participants · Phase 3

    Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

  • NCT06143956 · 1,217 participants · Phase 2

    A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

  • NCT05827016 · 1,216 participants · Phase 3

    A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma

  • NCT05946044 · 1,230 participants · NA

    The Osteoarthritis Prevention Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02729831, the US trial registry maintained by the National Library of Medicine. NCT02729831 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.